Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 5,500 shares at $83.13 ($457K) on 2025-06-16, disclosed to the SEC on 2025-06-18.
Scheduled sale ($457k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.13 | 2,750 | $229K | 50.0% |
| 2 | $83.13 | 2,750 | $229K | 50.0% |
| Total | $83.13 avg | 5,500 | $457K | 100% |
| Filing → |
| AMN | SELL | 2026-06-17 | $114K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |